Literature DB >> 6993218

Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesions.

H Sinzinger, W Feigl, K Silberbauer, R Oppolzer, M Winter, W Auerswald.   

Abstract

Unaltered human arterial tissue as well as different types of macroscopically and microscopically characterized atherosclerotic lesions were microdissected under a preparation microscope. The prostacyclin formation was examined using its potent platelet aggregation inhibition in vitro according to Moncada's bioassay. In contrast to different PGI2-formation in various experimental animal models the generation in the different lesion types in terms of wet weight was statistically significantly (p less than 0.001) diminished in comparison to normal control tissue. However, the PGI2- formation in different lesion types is comparable. Accepting the hypothesis delivered earlier by us, that the arterial wall is able to react upon exogenous noxes with a temporarily enhanced PGI2-formation, followed (after ceasing) by a decrease of PGI2-synthesis (exhaustion phenomenon) it can be concluded, that the critical stage is prior to the fatty streak formation, which is a preatherosclerotic lesion. Therefore, PGI2-generation-exhaustion might be mainly responsible for initiation and progression of atherosclerosis, probably before any detectable morphological alterations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993218     DOI: 10.1016/s0014-4908(80)80018-4

Source DB:  PubMed          Journal:  Exp Pathol (Jena)        ISSN: 0014-4908


  3 in total

1.  Influence of nicotine on basal and stimulated prostaglandin biosynthesis in perfused vascular tissue of the rabbit.

Authors:  H Juan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

2.  Vitamin C increases the formation of prostacyclin by aortic rings from various species and neutralizes the inhibitory effect of 15-hydroperoxy-arachidonic acid.

Authors:  J R Beetens; A G Herman
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

3.  Prostacyclin infusion in patients with acute myocardial infarction.

Authors:  P Henriksson; O Edhag; A Wennmalm
Journal:  Br Heart J       Date:  1985-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.